Dermapharm: Reppegather case becomes a problem for pharmaceutical billionaire Beier

The Bafin is supposed to examine transactions between the pharmaceutical company Dermapharm and the Reppegather brothers. It's about a claim worth millions and possible violations of accounting regulations.